Ironwood Financial’s Legend Biotech LEGN Stock Holding History

Ironwood Financial’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	-$2K	–	361
2021 Q3	$2K	Buy	+40	New	+$1.66K	﹤0.01%	512

Other funds holding LEGN

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Ironwood Financial's LEGN Position: Q4 2021 in Review

Ironwood Financial sold out of Legend Biotech (LEGN) in Q4 2021, closing a stake of 40 shares — an estimated $2K sold.

Ironwood Financial first reported a position in LEGN in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 139 funds tracked by Wall St. Rank hold LEGN as of Q4 2021.

Ironwood Financial reported no remaining Legend Biotech position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 40 Legend Biotech shares in Q4 2021, an estimated $2K.
Ironwood Financial first reported a position in Legend Biotech in Q3 2021 and held it in 1 quarter.
Ironwood Financial's Legend Biotech position peaked at $2K in Q3 2021.
139 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.